Shirley L. Paddock
Durham
Summary
Results and business focused drug development leader and a trusted member of senior leadership with an ability to influence across all levels of an organization. Demonstrated success in P&L management, leading and navigating governance, leading pharmaceutical alliances, navigating academic and venture capital partnerships, and strategic planning and portfolio management across all phases of drug development. Recognized as an individual who is adept at building and maintaining relationships. An accomplished leader, mentor, and communicator.
Overview
25
25
years of professional experience
Work History
Senior Vice President, Business Unit Head, Clinical Development
Syneos Health
05.2021 - Current
- Executive leadership accountability for strategic standalone business unit with Top 10 Pharma partner
- Responsible for strategic direction, financial profitability (P&L), and delivery of~$400m enterprise book of work spanning early to late phase clinical development
- Accountable for account growth and overall health of the strategic partnership
- Member of joint strategic governance committee.
Vice President, R&D Program and Portfolio Management
Liquidia Technologies
07.2019 - 01.2024
- Leadership accountability for establishing and leading robust program and portfolio management capabilities and processes, including scope management, the creation of efficient and transparent governance processes and decision making, cross functional communications and efficient operations of all R&D programs in the company portfolio
- Operations leadership responsibility for the Executive Leadership Team and R&D governance
- Accountable for the development and implementation of robust alliance management processes enabling successful corporate partnerships.
Senior Director, Thoracic Oncology, External Engagement & Program Leader
Eli Lilly & Company
09.2016 - 12.2017
- Program leadership responsibility for Lilly’s thoracic assets, including the integration and sustainability of the platform structure across the oncology business unit and the creation of a thoracic focused external engagement strategy.
Senior Director, Integration Leader Eli Lilly Next Generation Development
Eli Lilly & Company
09.2014 - 08.2016
- Strategically steered the integration of 70+ new capabilities and technologies into the Lilly drug development operating system
- Accountable to executive leadership with a budget of approximately $4m.
Senior Director, Chief Operating Officer – ChorusTM
Eli Lilly & Company
01.2010 - 09.2014
- Leveraged broad scope of drug development knowledge in directing all operational aspects of an autonomous, lean to proof-of-concept R&D unit within Lilly
- Responsible for delivering the ChorusTM portfolio of drug candidates through phase 2a proof of concept, including assets in a VC-backed project focused company model
- Cost-effectively managed a $25 million budget while overseeing clinical operations, portfolio governance, third-party procurement and contracting.
Senior Director, Portfolio Management - Early & Late Development
Eli Lilly & Company
01.2003 - 12.2009
- Functional leadership responsibility for all senior drug development program management experts
- Key responsibilities included senior R&D governance interactions, portfolio management and reporting, talent management, internal customer relationship management, leading issues management teams, after action reviews and multiple cross functional optimization projects
- Chief of Staff responsibilities for the late phase executive leader.
Senior Director, Program Leader, Late Phase Development
Eli Lilly & Company
06.1999 - 12.2003
- Program leadership responsibility for multiple drug development teams in late phase drug development, including commercialized assets in the oncology space
- Leadership responsibility for the development of integrated program plans designed to achieve the overall strategy and vision for assets, including life cycle management
- Direct accountability for establishing and managing critical milestones, directing cross-functional resources and direct spend, creating highly motivated teams to maximize project success and influencing across a complex matrix structure.
Accomplishments
- Outstanding Leadership Award, Women in Bio (2023)
- Purdue College of Pharmacy Women Leadership Award (2013)
- Julius W. Sturmer Memorial Lecture Award – Philadelphia College of Pharmacy (2009)
- Eli Lilly’s Women’s Network Mentor of the Year (2001)
Education
Master of Business Administration, Northwestern University, Bachelor of Science in Pharmacy, Purdue University, Registered Pharmacist – Indiana, Registered Pharmacist – Florida, Registered Pharmacist – North Carolina
Affiliations
- Women in Bio- RTP Chapter, Chair, Executive Mentoring Program Leader, 2020+
- Eshelman Institute for Innovation Advisory Board, UNC Eshelman School of Pharmacy, 2020+
- Purdue College of Pharmacy – Dean’s Advisory Council, 2017, 2024
- Pharmacy Women for Purdue, Executive Committee, 2008, 2019
- Providence Cristo Rey High School, Corporate Work Study Board, 2015, 2019
- Annual STEM Conference for Middle School Girls in Indiana, Instructor & Program Developer, 2009, 2015
- Purdue Alumni Association, National Board of Directors, 1996, 1999
Presentations
- IPhO Seminar, Creighton School of Pharmacy, November 2023
- Taking the Pulse at NCBio, October 2023
- Women’s Health Multidisciplinary Consortium, School of Medicine, UNC-Chapel Hill, February 2023
- NC House of Representatives Select Committee on Advancing Women in STEM, August 2022
- “Career Opportunities in Pharmacy” Indiana Pharmacist Alliance Annual Convention, September 2017
- Women’s Clinical Leadership Forum, “Mentoring the Next Generation of Rising Stars”. IIR’s Partnership in Clinical Trials Conference, April 2014
- Center for Biomedical Innovation (CBI) New Drug Development Paradigms Working Group, Mass. Institute of Technology (MIT), 2009
- Drug Information Association (DIA) Annual Meeting, June 2003
Timeline
Senior Vice President, Business Unit Head, Clinical Development
Syneos Health
05.2021 - Current
Vice President, R&D Program and Portfolio Management
Liquidia Technologies
07.2019 - 01.2024
Senior Director, Thoracic Oncology, External Engagement & Program Leader
Eli Lilly & Company
09.2016 - 12.2017
Senior Director, Integration Leader Eli Lilly Next Generation Development
Eli Lilly & Company
09.2014 - 08.2016
Senior Director, Chief Operating Officer – ChorusTM
Eli Lilly & Company
01.2010 - 09.2014
Senior Director, Portfolio Management - Early & Late Development
Eli Lilly & Company
01.2003 - 12.2009
Senior Director, Program Leader, Late Phase Development
Eli Lilly & Company
06.1999 - 12.2003
Similar Profiles
Lauren M. Wahl-RiversLauren M. Wahl-Rivers
Clinical Research Associate II at Syneos HealthClinical Research Associate II at Syneos Health
Marshonda WootenMarshonda Wooten
Engagement Center Specialist at Syneos HealthEngagement Center Specialist at Syneos Health
Marie Emmanuelle Koffi KouameMarie Emmanuelle Koffi Kouame
Results Analyst II – Immunology at Syneos HealthResults Analyst II – Immunology at Syneos Health
Ayanna KingAyanna King
REMS Specialist at Syneos HealthREMS Specialist at Syneos Health
Victoria WilliamsVictoria Williams
Package Handler at FedEx:GroundPackage Handler at FedEx:Ground